Diamond Biofund (TPE:6901) Shares Outstanding (EOP): 852.75 Mil (As of Dec. 2025)


TPE:6901 Diamond Biofund Inc TPE:6901
16 GF Score
Price NT$18.80
! 1 Warning Sign
View Full Analysis

What is Diamond Biofund Shares Outstanding (EOP)?

Diamond Biofund TPE:6901 +4.16% 16 Shares Outstanding (EOP) is 852.75 Mil as of Dec. 2025. GuruFocus rates TPE:6901 with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Diamond Biofund's shares outstanding for the quarter that ended in Dec. 2025 was 852.75 Mil.

Diamond Biofund's quarterly shares outstanding increased from Sep. 2025 (851.97 Mil) to Dec. 2025 (852.75 Mil). It means Diamond Biofund issued new shares from Sep. 2025 to Dec. 2025 .

Diamond Biofund's annual shares outstanding increased from Dec. 2024 (851.39 Mil) to Dec. 2025 (852.75 Mil). It means Diamond Biofund issued new shares from Dec. 2024 to Dec. 2025 .


Diamond Biofund  (TPE:6901) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Diamond Biofund Shares Outstanding (EOP) Related Terms


Diamond Biofund Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Diamond Biofund's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamond Biofund Shares Outstanding (EOP) Chart

Diamond Biofund Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial 749.30 749.30 849.89 851.39 852.75

Diamond Biofund Quarterly Data
Dec19 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 851.39 851.80 851.97 851.97 852.75

TPE:6901 vs BLK, BX, KKR: Shares Outstanding (EOP) Comparison

For the Asset Management subindustry, Diamond Biofund's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamond Biofund Shares Outstanding (EOP) vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Diamond Biofund's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Diamond Biofund's Shares Outstanding (EOP) falls into.


TPE:6901
16GF Score
Diamond Biofund Inc TPE:6901
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diamond Biofund Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 852.75 Mil mean?
Diamond Biofund (TPE:6901) has a Shares Outstanding (EOP) of 852.75 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Diamond Biofund and its competitors.
Is Diamond Biofund's Shares Outstanding (EOP) too high?
Diamond Biofund's current Shares Outstanding (EOP) is 852.75 Mil. Overall, Diamond Biofund has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Diamond Biofund's Shares Outstanding (EOP) compare to BLK and BX?
Diamond Biofund's Shares Outstanding (EOP) of 852.75 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for an Asset Management company?
A good Shares Outstanding (EOP) depends on the Asset Management industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Diamond Biofund and its competitors. Diamond Biofund's current Shares Outstanding (EOP) is 852.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biofund stock overvalued right now?
Diamond Biofund (TPE:6901) has a current Shares Outstanding (EOP) of 852.75 Mil. The current Shares Outstanding (EOP) is 852.75 Mil. Diamond Biofund's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Diamond Biofund (TPE:6901), the current Shares Outstanding (EOP) is 852.75 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diamond Biofund Business Description

Address Zhongxiao West Road, 34th Floor, No. 66, Section 1, Zhongzheng District, Taipei, TWN, 100
Diamond Biofund Inc is a sustainable biotech venture capital that focuses on the field of biotechnology and medical investment, targeting competitive investment targets, including new drug research and development, high-end medical equipment, medical service technology, medical access, agricultural biotechnology.
16GF Score

Get the complete analysis for TPE:6901

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.80
Price